Lipiduce 160

Lipiduce 160

fenofibrate

Manufacturer:

Unison

Distributor:

JustRight Healthcare
Concise Prescribing Info
Contents
Fenofibrate
Indications/Uses
To reduce LDL cholesterol, total cholesterol, triglycerides, apolipoprotein B & increase HDL cholesterol, in the management of hyperlipidemias including type IIa, type IIb, type III, type IV & type V hyperlipoproteinemias.
Dosage/Direction for Use
Adult Hypercholesterolemia, primary hypercholesterolemia or mixed dyslipidemia (Fredrickson type 2a, 2b) 160 mg daily. Max: 160 mg/day. Hypertriglyceridemia, Fredrickson types 4 & 5 hyperlipidemia Adjunct to diet: Initially 50-160 mg once daily, adjust dose after repeated lipid tests at 4-8 wk intervals. Max: 160 mg orally daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Gallbladder disease, active liver disease. Severe renal dysfunction. Lactation.
Special Precautions
Concomitant therapy w/ HMG-CoA reductase inhibitors (eg, lovostatin, pravastatin, simvastatin) or fenofibric acid derivatives (eg, gemfibrozil) should be avoided, concomitant therapy w/ anticoagulants, cholelithiasis, diabetic patients, hypothyroidism, hypersensitivity reactions, myopathies, pancreatitis, renal dysfunction, serum transaminases (AST & ALT) increases of >3 times the upper limit of normal. Childn. Elderly.
Adverse Reactions
Rash, diarrhea, flatulence, nausea & vomiting, myalgia, rhinitis.
Drug Interactions
Acenocoumarol, anisindione, atorvastatin, cerivastatin, dicumarol, fluvastatin, lovastatin, phenindione, phenprocoumon, pravastatin, rosuvastatin, simvastatin, warfarin, colestipol, ezetimibe, glimepiride.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Lipiduce 160 FC tab 160 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in